Cambridgeshire Joint Prescribing Group Decision Document

A Dipeptidyl peptidase (DPP-4) inhibitor Date of last revision 19 July, version 1(1) Prepared by Debbie Morrison, Consultant Pharmacist, CJPG and HCD, Katie Smith, Director, East Anglia Medicines Information Service. Document status For consideration by CJPG at the May 2012 meeting Purpose of Document To inform clinicians about an impending new drug, review information currently available and give guidance on potential use and assign a R-A-G classification. Recommendations It is recommended by Cambridgeshire JPG members, and through them to local NHS organisations, that the arrangements for use of linagliptin are as a Green drug and the drug is suitable for prescribing in both primary and secondary care but with restrictions on place in therapy.